Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)
4.135
-0.555
(-11.83%)
Streaming Delayed Price
Updated: 12:48 PM EDT, Jul 31, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 10,902,297 |
| Open | 4.430 |
| Bid (Size) | 4.130 (33,800) |
| Ask (Size) | 4.140 (16,000) |
| Prev. Close | 4.690 |
| Today's Range | 4.020 - 4.550 |
| 52wk Range | 1.760 - 5.640 |
| Shares Outstanding | 305,252,194 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
This Stock Is Up 74% This Year: Is It Too Late to Buy? ↗
July 08, 2026
Iovance (IOVA) Q1 2026 Earnings Transcript ↗
May 08, 2026
Frequently Asked Questions
Is Iovance Biotherapeutics, Inc. - Common Stock publicly traded?
Yes, Iovance Biotherapeutics, Inc. - Common Stock is publicly traded.
What exchange does Iovance Biotherapeutics, Inc. - Common Stock trade on?
Iovance Biotherapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock?
The ticker symbol for Iovance Biotherapeutics, Inc. - Common Stock is IOVA on the Nasdaq Stock Market
What is the current price of Iovance Biotherapeutics, Inc. - Common Stock?
The current price of Iovance Biotherapeutics, Inc. - Common Stock is 4.135
When was Iovance Biotherapeutics, Inc. - Common Stock last traded?
The last trade of Iovance Biotherapeutics, Inc. - Common Stock was at 07/31/26 12:48 PM ET
What is the market capitalization of Iovance Biotherapeutics, Inc. - Common Stock?
The market capitalization of Iovance Biotherapeutics, Inc. - Common Stock is 1.26B
How many shares of Iovance Biotherapeutics, Inc. - Common Stock are outstanding?
Iovance Biotherapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.